Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05
(0.33%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma acquires 51% stake in Natco Organics
>>
Natco Pharma informs outcome of board meeting
>>
Natco Pharma surges on starting sale of compulsorily licensed drug- Nexavar
>>
Natco Pharma begins sale of compulsorily licensed drug- Nexavar
>>
Natco Pharma plunges on losing US case on generic Copaxone
>>
Natco Pharma loses US case on generic Copaxone
>>
Natco Pharma board revises the remuneration of chairman
>>
Natco Pharma climbs higher on the bourses
>>
Natco Pharma wins ‘Golden Peacock Award’
>>
Natco Pharma granted with compulsory license for Sarofenib Tosylate
<<
<
50
51
52
>
>>